These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18902738)

  • 1. [Microbial resistance to chemotherapy drugs].
    SELBIE FR
    Dia Med; 1947 Jul; 19(36):1157-61. PubMed ID: 18902738
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbial resistance to chemotherapeutic drugs.
    SELBIE FR
    Br Med Bull; 1946; 4(4):267-71. PubMed ID: 20281778
    [No Abstract]   [Full Text] [Related]  

  • 3. CHEMOTHERAPY WITH SECONDARY DRUGS IN THE FAR ADVANCED CASES OF PULMONARY TUBERCULOSIS.
    OKA S
    Sci Rep Res Inst Tohoku Univ Med; 1965 Mar; 12():1-31. PubMed ID: 14331173
    [No Abstract]   [Full Text] [Related]  

  • 4. CHEMOTHERAPY OF PULMONARY TUBERCULOSIS IN ADULTS: THE CHOICE OF DRUGS IN RELATION TO DRUG SUSCEPTIBILITY. A STATEMENT OF THE COMMITTEE ON THERAPY.
    TSUKAMURA M
    Am Rev Respir Dis; 1965 Sep; 92():508-12. PubMed ID: 14346379
    [No Abstract]   [Full Text] [Related]  

  • 5. OPTIMAL REGIMENS OF CHEMOTHERAPY IN PATIENTS ALREADY TREATED, WITH BACILLI RESISTANT TO THE MAJOR ANTITUBERCULOUS DRUGS.
    TUCKER B
    Bull Int Union Tuberc; 1964 Sep; 35():151-5. PubMed ID: 14269363
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemotherapy and drug resistance of pathogens].
    Rische H; Tschäpe H
    Dtsch Gesundheitsw; 1972 Nov; 27(48):2296-9. PubMed ID: 4348270
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity tests by disc method as a guide for chemotherapy.
    TUNEVALL G; ERICSSON H
    Antibiot Chemother (Northfield); 1954 Aug; 4(8):886-93. PubMed ID: 24543215
    [No Abstract]   [Full Text] [Related]  

  • 8. [PROBLEMS OF CHRONIC TUBERCULOSIS. DETERMINATION OF RESISTANCE IN TREATMENT WITH SECONDARY DRUGS].
    KREBS A
    Z Tuberk Erkr Thoraxorg; 1964 Oct; 122():141-53. PubMed ID: 14330257
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recent chemotherapy].
    Okubo H
    Naika Hokan; 1968 Sep; 15(9):315-23. PubMed ID: 5752088
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE PRACTICAL CONSEQUENCES OF PRIMARY RESISTANCE OF KOCH'S BACILLUS TO ANTI-BACILLI DRUGS].
    BERNARD E; KREIS B
    Rev Prat; 1965 Jan; 15():275-82. PubMed ID: 14251074
    [No Abstract]   [Full Text] [Related]  

  • 11. [The troublesome progress of chemotherapy].
    Lang W
    MMW Munch Med Wochenschr; 1977 Oct; 119(42):1347-8. PubMed ID: 412068
    [No Abstract]   [Full Text] [Related]  

  • 12. [Factors determining resistance to the action of chemotherapeutics and antibiotics].
    KEMPSKI HW
    Sem Med; 1953 Feb; 102(9):274-7. PubMed ID: 13076490
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of chemotherapy.
    Lancet; 1969 May; 1(7601):930-1. PubMed ID: 4180905
    [No Abstract]   [Full Text] [Related]  

  • 14. CHEMOTHERAPY OF STAPHYLOCOCCAL INFECTIONS.
    HAMBURGER M
    Antimicrob Agents Chemother (Bethesda); 1963; 161():708-13. PubMed ID: 14274989
    [No Abstract]   [Full Text] [Related]  

  • 15. CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. II. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF ETHAMBUTOL, CAPREOMYCIN AND COMPANION DRUGS, INCLUDING 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE.
    KASS I
    Tubercle; 1965 Jun; 46():166-77. PubMed ID: 14327964
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problems in chemotherapy in hospitals and private practice].
    Metz H
    Ther Ggw; 1981 Dec; 120(12):1126-9. PubMed ID: 7330783
    [No Abstract]   [Full Text] [Related]  

  • 17. [STUDIES ON THE TRANSITION OF SENSITIVITY FOR SM, INH AND PAS OF TUBERCLE BACILLI ISOLATED FROM THE PATIENTS TREATED BY TRIPLE COMBINATION CHEMOTHERAPY INCLUDING SM AND INH WITH SPECIAL REFERENCE TO THEIR CLINICAL COURSE].
    OHSATO T; SHIMIZU H
    Kekkaku; 1965 Jan; 40():19-24. PubMed ID: 14288528
    [No Abstract]   [Full Text] [Related]  

  • 18. Principles of combination chemotherapy.
    Ambrus JL; Ambrus CM
    Am J Pharm Sci Support Public Health; 1970; 142(3):116-26. PubMed ID: 5514870
    [No Abstract]   [Full Text] [Related]  

  • 19. [Basic trends and the prospects for creating new synthetic chemotherapeutic preparations].
    Pershin GN
    Antibiotiki; 1980 Oct; 25(10):723-9. PubMed ID: 7425591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Future of chemotherapy].
    Umezawa H
    Saishin Igaku; 1969 Sep; 24(9):1915-9. PubMed ID: 5353800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.